Health-related quality of life in patients with unresectable hepatocellular carcinoma treated with SIRT and nivolumab: a sub-analysis of the NASIR-HCC trial

De la Torre-Aláez M, Matilla A, Varela M, Iñarrairaegui M, Reig M, Lledó JL, Arenas JI, Lorente S, Testillano M, Márquez L, Iserte G, Argemí J, Gómez-Martin C, Rodríguez-Fraile M, Bilbao JI, Pollock RF, Pöhlmann J, Agirrezabal I, Sangro B.

  2025
10.1186/s41687-025-00873-6